APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children

Pediatric Obesity

Volumn 12, Issue 4, 2017, Pages 330-336

  Suarez Sanchez F ^a   Klunder Klunder, M ^b   Valladares Salgado, A ^a   Gomez Zamudio J ^a   Peralta Romero, J ^a   Meyre, D ^c   Burguete Garcia A ^d   Cruz, M ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c MCMASTER UNIVERSITY   (Canada)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

APOA1; APOA5; rs662799 and rs5072; triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; GLUCOSE; TRIACYLGLYCEROL; APOA1 PROTEIN, HUMAN; APOA5 PROTEIN, HUMAN;

ADOLESCENT; AGE DISTRIBUTION; ALLELE; ANTHROPOMETRIC PARAMETERS; APOA1 GENE; APOA5 GENE; ARTICLE; BLOOD SAMPLING; BODY MASS; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEXICAN; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ANTHROPOMETRY; BLOOD; ETHNOLOGY; GENETICS; HYPERTRIGLYCERIDEMIA; MEXICAN AMERICAN; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ALLELES; ANTHROPOMETRY; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-V; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MEXICAN AMERICANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRIGLYCERIDES;

EID: 84969754518     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/ijpo.12147     Document Type: Article

References (29)

1. Koskinen J, Magnussen CG, Sabin MA, et al. Youth overweight and metabolic disturbances in predicting carotid intima-media thickness, type 2 diabetes, and metabolic syndrome in adulthood: the Cardiovascular Risk in Young Finns study. Diabetes Care 2014; 37: 1870–1877.
2. Leibowitz KL, Moore RH, Stunkard AJ, et al. Cardiovascular disease risk factor (CVDRF) associated waist circumference patterns in obese-prone children. International Journal of Pediatric Obesity : IJPO : An Official Journal of the International Association for the Study of Obesity 2009; 4: 150–159.
3. Klunder-Klunder M, Flores-Huerta S, Garcia-Macedo R, Peralta-Romero J, Cruz M. Adiponectin in eutrophic and obese children as a biomarker to predict metabolic syndrome and each of its components. BMC Public Health 2013; 13: 88.
4. Gutiérrez JPR-DJ, Shamah-Levy T, Villalpando-Hernández S, et al. Resultados Nacionales. Instituto Nacional de Salud Publica: Cuernavaca, México, 2012.
5. Farook VS, Reddivari L, Chittoor G, et al. Metabolites as novel biomarkers for childhood obesity-related traits in Mexican-American children. Pediatric Obesity 2015; 10: 320–327.
6. Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 2011; 377: 529–532.
7. Hobkirk JP, King RF, Davies I, et al. The metabolic inter-relationships between changes in waist circumference, triglycerides, insulin sensitivity and small, dense low-density lipoprotein particles with acute weight loss in clinically obese children and adolescents. Pediatric Obesity 2014; 9: 209–217.
8. Brinton EA. Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease. Cardiol Clin 2015; 33: 309–323.
9. Kell KP, Cardel MI, Bohan Brown MM, Fernandez JR. Added sugars in the diet are positively associated with diastolic blood pressure and triglycerides in children. Am J Clin Nutr 2014; 100: 46–52.
10. Aguilar-Salinas CA, Tusie-Luna T, Pajukanta P. Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemia. Metabolism: Clinical and Experimental 2014; 63: 887–894.
11. Johansen CT, Hegele RA. Allelic and phenotypic spectrum of plasma triglycerides. Biochim Biophys Acta 1821; 2012: 833–842.
12. Garelnabi M, Lor K, Jin J, Chai F, Santanam N. The paradox of APOA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem 2013; 46: 12–19.
13. Lu R, Arakawa R, Ito-Osumi C, Iwamoto N, Yokoyama S. APOA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation. Arterioscler Thromb Vasc Biol 2008; 28: 1820–1824.
14. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004; 110: 2494–2497.
15. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005; 21: 263–265.
16. Vinueza R, Boissonnet CP, Acevedo M, et al. Dyslipidemia in seven Latin American cities: CARMELA study. Prev Med 2010; 50: 106–111.
17. Schusterova I, Leenen FH, Jurko A, Sabol F, Takacova J. Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. Pediatr Obes 2014; 9: 63–70.
18. Marquez-Sandoval F, Macedo-Ojeda G, Viramontes-Horner D, Fernandez Ballart JD, Salas Salvado J, Vizmanos B. The prevalence of metabolic syndrome in Latin America: a systematic review. Public Health Nutr 2011; 14: 1702–1713.
19. Miranda JJ, Herrera VM, Chirinos JA, et al. Major cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO). PLoS One 2013; 8: e54056.
20. Novotny D, Karasek D, Vaverkova H, Slavik L. The influence of apolipoprotein A5 T-1131C and apolipoprotein E common genetic variants on the levels of hemostatic markers in dyslipidemic patients. Clinica Chimica Acta; Int J Clin Chem 2014; 436: 11–17.
21. Xu C, Bai R, Zhang D, et al. Effects of APOA5 -1131 T > C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis. PLoS One 2013; 8: e56216.
22. Dodani S, Henkhaus R, Wick J, et al. Metabolic syndrome in South Asian immigrants: more than low HDL requiring aggressive management. Lipids Health Dis 2011; 10: 45–45.
23. Elder SJ, Lichtenstein AH, Pittas AG, et al. Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome. J Lipid Res 2009; 50: 1917–1926.
24. Zhu WF, Wang CL, Liang L, et al. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents. Lipids Health Dis 2014; 13: 93.
25. Horvatovich K, Bokor S, Barath A, et al. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients. International Journal of Pediatric Obesity : IJPO : An Official Journal of the International Association for the Study of Obesity 2011; 6: e318–325.
26. Fatemi SG, Emadi-Baygi M, Nikpour P, Kelishadi R, Hashemipour M. Absence of association between -1131 T > C polymorphism in the apolipoprotein APOA5 gene and pediatric metabolic syndrome. Iran J Pediatr 2014; 24: 319–322.
27. Nilsson SK, Heeren J, Olivecrona G, Merkel M. Apolipoprotein A-V; a potent triglyceride reducer. Atherosclerosis 2011; 219: 15–21.
28. Henkhaus RS, Dodani S, Manzardo AM, Butler MG. APOA1 gene polymorphisms in the South Asian immigrant population in the United States. Indian J Hum Genet 2011; 17: 194–200.
29. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2011.